2027 will be the year that FDA approval is sought. Merck and IMM need that in 2027 because Keytruda expires in 2028. If there is any indication in 2025-26 that this combo is working well then I think we can expect an aquisition and Merck will then build their processing plant in USA as USA may block any Efti manufactured in China.
Ann: Immutep announces Ph 3 clinical trial collaboration with MSD, page-9
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.010(3.17%) |
Mkt cap ! $443.6M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.8¢ | 30.5¢ | $1.050M | 3.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 334744 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 5285 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |